A test for pee-based markers of prostate cancer has previously relied on an uncomfortable first step. A new study has revealed that the now-available test remains just as accurate without it, paving ...

With rising global cancer rates necessitating new forms of diagnosis and treatment, Hong Kong-based biotech startup Phase Scientific International announced Tuesday it raised $34 million in a Series A ...